Clinical Trials Directory

Trials / Completed

CompletedNCT05485012

Reinforcing Effects of Marijuana and Opioids

Modulation of Drug Intake: Evaluation of Opioid and Cannabinoid Interactions on Drug Self-Administration

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Shanna Babalonis, PhD · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The primary goals of this study are to examine 1) marijuana modulation of oxycodone self-administration and 2) oxycodone modulation of marijuana self-administration, under controlled conditions and across a range of doses for each drug.

Conditions

Interventions

TypeNameDescription
DRUGMarijuanaDouble-blind administration of marijuana
DRUGOpioidDouble-blind administration of an opioid agonist

Timeline

Start date
2023-08-03
Primary completion
2025-03-27
Completion
2025-03-27
First posted
2022-08-02
Last updated
2026-04-15
Results posted
2026-04-15

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05485012. Inclusion in this directory is not an endorsement.